Paraoxonase 1 (PON1) shows promise as a risk factor for AD, mainly due to its anti-inflammatory and anti-apoptotic properties, as low PON1 activity levels correlate with advanced disease. This evidence concerns the gene PON1 and Alzheimer disease.